Breaking News

Tweet TWEET

Dividends and Recognitions Affirming Strong Returns to Shareholders- Research Report on Merck, AbbVie, HealthSouth, Quintiles,

Dividends and Recognitions Affirming Strong Returns to Shareholders- Research
         Report on Merck, AbbVie, HealthSouth, Quintiles, and Ensign

PR Newswire

NEW YORK, September 25, 2013

NEW YORK, September 25, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

Today, Investors' Reports announced new research reports highlighting Merck &
Co. Inc. (NYSE: MRK), AbbVie Inc. (NYSE: ABBV), HEALTHSOUTH Corp. (NYSE: HLS),
Quintiles Transnational Holdings Inc. (NYSE: Q), and The Ensign Group, Inc.
(NASDAQ: ENSG). Today's readers may access these reports free of charge -
including full price targets, industry analysis and analyst ratings - via the
links below.

Merck & Co. Inc.Research Report

On September 17, 2013, Merck & Co. (Merck) announced that it has been
recognized as one of the Working Mother 100 Best Companies for 2013, for the
26th year. The Company informed that it has been selected in the list for its
commitment to progressive workplace programs, including female representation,
compensation, child care, flexibility, time off and leave, family-friendly
programs, and company culture. Dottie Brienza, Chief Diversity Officer and
Executive Talent Leader, Merck said, "This award recognizes Merck's commitment
to fostering an environment where all employees, including working parents and
those who provide care for others, can effectively integrate work and life,
take care of themselves and their families and reach their professional
goals." The Full Research Report on Merck & Co. Inc. - including full detailed
breakdown, analyst ratings and price targets - is available to download free
of charge at: [http://www.investorsreports.com/report/2013-09-23/MRK]

AbbVie Inc.Research Report

On September 19, 2013, AbbVie Inc. (AbbVie) announced that its Board of
Directors has authorized a quarterly cash dividend of $0.40 per share to be
payable on November 15, 2013, to stockholders of record at the close of the
business on October 15, 2013. The Company stated that AbbVie, which was
created in 2013 after being separated from Abbott, was selectedin the S&P
Dividend Aristocrats Index, as a result of the Index's change in its treatment
of spin-off companies. According to AbbVie, the S&P Dividend Aristocrats Index
tracks companies that have annually increased their dividend for at least 25
consecutive years. The Full Research Report on AbbVie Inc. - including full
detailed breakdown, analyst ratings and price targets - is available to
download free of charge at:
[http://www.investorsreports.com/report/2013-09-23/ABBV]

HEALTHSOUTH Corp.Research Report

On September 12, 2013, HealthSouth Corp. (HealthSouth) announced that its
Board of Directors has approved a quarterly cash dividend of $16.25 per share
on its 6.5% Series A Convertible Perpetual Preferred Stock, payable on October
15, 2013, to holders of record on October 1, 2013. The Company also informed
that in line with its previous announcement, the Board has also declared an
initial quarterly cash dividend of $0.18 per share on its common stock,
payable on October 15, 2013, to holders of record as on October 1, 2013. The
Full Research Report on HEALTHSOUTH Corp. - including full detailed breakdown,
analyst ratings and price targets - is available to download free of charge
at: [http://www.investorsreports.com/report/2013-09-23/HLS]

Quintiles Transnational Holdings Inc.Research Report

On September 9, 2013, Quintiles Transnational Holdings Inc. (Quintiles)
announced that it has been awarded for its leadership in business technology
innovation as it has been included in the InformationWeek 500 for the fifth
consecutive year. According to the Company, over the period of past five
years, InformationWeek has honored Quintiles for various industry leading
business technology innovations across the drug development continuum.
Quintiles stated that it has created an industry-wide platform, Infosario
Safety, which addresses the challenges of managing drug safety to improve
patient outcomes and drive compliance with changing regulatory requirements
while enhancing quality and productivity across a product's lifecycle.
Quintiles stated that InformationWeek identifies and recognizes the nation's
most innovative users of information technology with its annual
InformationWeek 500 listing, and also tracks the technology, strategies,
investments and administrative practices of some of the best-known
organizations in the country. The Full Research Report on Quintiles
Transnational Holdings Inc. - including full detailed breakdown, analyst
ratings and price targets - is available to download free of charge at:
[http://www.investorsreports.com/report/2013-09-23/Q]

The Ensign Group, Inc.Research Report

On September 19, 2013, The Ensign Group, Inc.(Ensign) announced that its Board
of Directors has approved a quarterly cash dividend in the amount of c.$0.07
per share of Ensign common stock. According to the Company, the dividend is
payable on or before October 31, 2013 to shareholders of record as on
September 30, 2013. Ensign informed that it has been paying dividends since
2002. The Full Research Report on The Ensign Group, Inc. - including full
detailed breakdown, analyst ratings and price targets - is available to
download free of charge at:
[http://www.investorsreports.com/report/2013-09-23/ENSG]

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by Namrata Maheshwari, a CFA charterholder. However, we
    are only human and are prone to make mistakes. If you notice any errors or
    omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Namrata Maheshwari,
CFA, has only reviewed the information provided by Equity News Network in this
article or report according to the Procedures outlined by Equity News Network.
Equity News Network is not entitled to veto or interfere in the application of
such procedures by the outsourced provider to the articles, documents or
reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
Institute.

http://www.InvestorsReports.com

SOURCE Investors' Reports

Contact: Media Contact: Kristi Saunders, +1-315-982-6420 (North America)
 
Press spacebar to pause and continue. Press esc to stop.